Can-Fite BioPharma Holds Annual Shareholder Meeting
Ticker: CANF · Form: 6-K · Filed: Jul 3, 2024 · CIK: 1536196
| Field | Detail |
|---|---|
| Company | Can-Fite Biopharma LTD. (CANF) |
| Form Type | 6-K |
| Filed Date | Jul 3, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: shareholder-meeting, sec-filing, corporate-governance
TL;DR
Can-Fite BioPharma held its annual shareholder meeting on July 3, 2024, filing a 6-K.
AI Summary
On July 3, 2024, Can-Fite BioPharma Ltd. filed a Form 6-K to incorporate by reference into its existing registration statements. This filing relates to the company's Annual General Meeting of Shareholders held on the same date.
Why It Matters
This filing serves to update and incorporate information into existing SEC registration statements, ensuring transparency for investors regarding company governance and shareholder matters.
Risk Assessment
Risk Level: low — This is a routine administrative filing (Form 6-K) related to a shareholder meeting, with no new financial or operational disclosures that would indicate significant risk.
Key Players & Entities
- Can-Fite BioPharma Ltd. (company) — Registrant
- July 3, 2024 (date) — Date of Annual General Meeting and Filing
FAQ
What is the purpose of this Form 6-K filing?
The Form 6-K is filed to report information to the SEC and is incorporated by reference into Can-Fite BioPharma Ltd.'s existing registration statements on Form S-8 and Form F-3.
When was the Annual General Meeting of Shareholders held?
The Annual General Meeting of Shareholders of Can-Fite BioPharma Ltd. was held on July 3, 2024.
What is Can-Fite BioPharma Ltd.'s principal executive office address?
The principal executive offices are located at 26 Ben Gurion Street, Ramat Gan, 5257346, Israel.
Which SEC registration statements does this 6-K filing get incorporated into?
This filing is incorporated into Can-Fite BioPharma Ltd.'s Registration Statements on Form S-8 (File Nos. 333-227753, 333-271384, and 333-278525) and Form F-3 (File Nos. 333-195124, 333-236064, 333-249063, 333-262055, and 333-276000).
What is the SIC code for Can-Fite BioPharma Ltd.?
The Standard Industrial Classification (SIC) code for Can-Fite BioPharma Ltd. is 2834, Pharmaceutical Preparations.
Filing Stats: 297 words · 1 min read · ~1 pages · Grade level 11.7 · Accepted 2024-07-03 13:15:24
Filing Documents
- ea020894801-6k_canfite.htm (6-K) — 9KB
- 0001213900-24-058931.txt ( ) — 10KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: July 3, 2024 By: /s/ Motti Farbstein Motti Farbstein Chief Executive Officer and Chief Financial Officer